CN102600414B - 一种治疗颈椎病的中药组合物 - Google Patents
一种治疗颈椎病的中药组合物 Download PDFInfo
- Publication number
- CN102600414B CN102600414B CN2012100575851A CN201210057585A CN102600414B CN 102600414 B CN102600414 B CN 102600414B CN 2012100575851 A CN2012100575851 A CN 2012100575851A CN 201210057585 A CN201210057585 A CN 201210057585A CN 102600414 B CN102600414 B CN 102600414B
- Authority
- CN
- China
- Prior art keywords
- radix
- drugs
- rhizoma
- cervical spondylosis
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 claims abstract description 103
- 229940079593 drug Drugs 0.000 claims abstract description 49
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims abstract description 27
- 208000036319 cervical spondylosis Diseases 0.000 claims abstract description 26
- 208000005801 spondylosis Diseases 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 241000721047 Danaus plexippus Species 0.000 claims abstract description 15
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 241001127714 Amomum Species 0.000 claims abstract description 8
- 239000002671 adjuvant Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims description 20
- 241000237636 Pheretima Species 0.000 claims description 11
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 241000903946 Clematidis Species 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 10
- 241000283956 Manis Species 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- 210000003038 endothelium Anatomy 0.000 claims description 7
- 239000010271 massa medicata fermentata Substances 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 241000756943 Codonopsis Species 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004185 liver Anatomy 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 36
- 230000001737 promoting effect Effects 0.000 abstract description 31
- 210000003734 kidney Anatomy 0.000 abstract description 29
- 230000017531 blood circulation Effects 0.000 abstract description 25
- 210000002784 stomach Anatomy 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 16
- 210000000988 bone and bone Anatomy 0.000 abstract description 14
- 210000003205 muscle Anatomy 0.000 abstract description 12
- 238000005728 strengthening Methods 0.000 abstract description 12
- 238000010792 warming Methods 0.000 abstract description 8
- 230000029087 digestion Effects 0.000 abstract description 7
- 230000000857 drug effect Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000005906 menstruation Effects 0.000 abstract description 3
- 239000006187 pill Substances 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 239000003826 tablet Substances 0.000 abstract description 3
- 235000013372 meat Nutrition 0.000 abstract description 2
- 241000510667 Conioselinum Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000006226 Areca catechu Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241000157491 Morinda Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000226566 Psoralea corylifolia Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 230000001846 repelling effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 230000002175 menstrual effect Effects 0.000 description 7
- 230000003119 painkilling effect Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003138 coordinated effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000019804 backache Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000002385 vertebral artery Anatomy 0.000 description 2
- 208000029761 vertebral disease Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XOHUEYCVLUUEJJ-UHFFFAOYSA-I 2,3-Diphosphoglycerate Chemical compound [O-]P(=O)([O-])OC(C(=O)[O-])COP([O-])([O-])=O XOHUEYCVLUUEJJ-UHFFFAOYSA-I 0.000 description 1
- ZTKQHJHANLVEBM-UHFFFAOYSA-N 2-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoic acid Chemical compound C1=2C=C(C)C(NCC)=CC=2OC2=CC(=NCC)C(C)=CC2=C1C1=CC=CC=C1C(O)=O ZTKQHJHANLVEBM-UHFFFAOYSA-N 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000008336 microcirculatory blood flow Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗颈椎病的中药组合物,其中,当归、丹参、乳香、没药、元胡、川芎、桃仁、红花、香附、土虫和甲珠共为君药;黄芪、白芍、巴戟肉、洋火叶、故纸、首乌、五味子、百合、生地、威灵仙和五加皮共为臣药;榔片、内金、草寇、炙山楂和神曲为佐药;川芎、葛根、地龙、全虫冰片、枳实和元胡共为使药。君药活血化瘀,祛瘀止痛,活血通经;臣药补肝肾,强筋骨,去风湿;佐药消食健胃,温中祛寒,饮食入胃,滋生正气保护中焦不受药气所伤;使药调和诸药气,引诸药入经,直达病灶。通过大量临床及药理研究已证明,组方精妙,药性协调,药效可靠持久。痊愈为75%,有效为15%,总有效为90%。可以制成丸、片、散及胶囊剂,是治疗颈椎病的有效药物。
Description
技术领域
本发明涉及一种治疗颈椎病的中药组合物,属于中药技术领域。
背景技术
颈椎病又称颈椎综合征,是颈椎骨关节炎、增生性颈椎炎、颈神经根综合征、颈椎间盘脱出症的总称,是一种以退行性病理改变为基础的疾患。主要由于颈椎长期劳损、骨质增生,或椎间盘脱出、韧带增厚,致使颈椎脊髓、神经根或椎动脉受压,出现一系列功能障碍的临床综合征。表现为颈椎间盘退变本身及其继发性的一系列病理改变,如椎节失稳、松动;髓核突出或脱出;骨刺形成;韧带肥厚和继发的椎管狭窄等,刺激或压迫了邻近的神经根、脊髓、椎动脉及颈部交感神经等组织,并引起各种各样症状和体征的综合征。本病属中医学“痹证”范畴。临床辨证主要分为肝肾亏虚、风寒湿痹两种类型。分类型进行辨证论治。
发明内容
为了丰富治疗治疗颈椎病的中药药物,本发明提供了一种治疗颈椎病的中药组合物。
一种治疗颈椎病的中药组合物,其特征在于,以君臣佐使组方,其配方及质量g配比为:黄芪30,党参20 ,当归20,丹参20,川芎10,白芍25,桃仁20,红花30,香附20,地龙25,葛根20,生地25,土虫10,威灵仙25,甲珠15,百合25,炙山楂15,神曲15,草蔻9,巴戟肉15,故纸15,洋火叶15,榔片15,内金15,枳实15,首乌25,五味子10,乳香25,没药15,川羌15,元胡20,冰片3,全虫3,五加皮25;
一种治疗颈椎病的中药组合物以君臣佐使组方。本发明的中医组方原则介绍如下:
当归,性温,味甘、辛。归肝、心、脾经。功能主治是补血活血、风湿痹痛、跌扑损伤。《注解伤寒论》记载:“通脉”。同时,现代研究记载当归煎剂耳血管灌注流,可使家兔子血管舒张,水提醇沉液静注可使麻醉犬动脉压下降,冠脉、脑动脉和股动脉阻力下降,血流量增加。
丹参,性味苦,微寒。归心、肝经。功效主治:活血调经,祛瘀止痛。可用于热痹疼痛,疮疡肿痛,跌仆伤痛。《本草汇言》:丹参,善治血分,去滞生新,调经顺脉之药也。现代研究表明,丹参及其丹参酮2A磺酸钠通过提高红细胞中2、3-二磷酸甘油酸含量和抑制钙高蛋白功能发挥稳定红细胞膜抗溶血作用,丹参注射液减少红细胞与内皮细胞粘附的作用,这些可能是其改善微循环的机制。
乳香,性味辛苦,温。入心、肝、脾经。《纲目》:调气活血,定痛,追毒,治气血凝滞。
没药,味苦辛,温,无毒。入肝、脾、心、肾经。《海药本草》:治跌打损伤、筋骨痛。
元胡,中医认为,元胡辛散、苦泄、温通,既入血分,又入气分,既能行血中之气,又能行气中之血,气畅血行,通则不痛。临床证实本品为中药中的止痛良药,配当归、川芎、乳香、没药,用于血滞疼痛;现代医学研究证实,元胡中可分离出15种生物碱。
川芎,味辛,性温。归肝、胆、心包经。功能主治是活血行气,祛风止痛,可用于跌扑肿痛,风湿痹痛。”《中药大辞典》记载其提取物川芎嗪静注可增加家兔肠系膜微循环血流量和微血管开放数目,在体处对由二磷酸腺苷、胶原和凝血酶诱导的家兔和人血小板聚集有显著抑制作用,并使已聚集的血小板迅速解聚。
桃仁,性味苦、甘,平。归心、肝、大肠经。功能主治:活血祛瘀,用于跌扑损伤。《本经逢原》:桃仁,为血瘀血闭之专药。现代研究表明,该品水煎醇沉液可使离体兔耳静脉血管流量增加,有舒张血管作用。给麻醉犬动脉注射,能增加股动脉血流量及降低血管阻力,对血管壁有直接扩张作用。该品还有抑制血液凝固和溶血作用。
红花,性味辛,温,归心、肝经,功效主治:活血通经,祛瘀止痛,可用于跌打损伤。《本草纲目》:活血,润燥,止痛,散肿,通经。《药品化义》:红花,善通利经脉,为血中气药,能泻而又能补,各有妙义。现代研究表明红花黄色素及黄Ⅱ、黄Ⅲ有改善外周微循环障碍作用, 使血流加速、毛细血管网开放数目增加和血细胞聚集程度减轻。
香附,性味微苦、微甘,平。归肝、脾、三焦经。《雷公炮制药性解》:"入肺、肝、脾、胃四经。功能主治,行气解郁。
土虫,《神农本草经》又名地鳖,其性寒、味咸,有毒,能入心肝脾三经,具有逐瘀、通络、理伤以及接骨续筋、消肿止痛、跌打瘀肿、筋骨骨折等病症。
甲珠 又名穿山甲。《中国药典》: 性味咸,微寒。归肝、胃经。功能主治:搜风通络,关节痹痛,麻木拘挛。
方中的当归、丹参、乳香、没药、元胡、川芎、桃仁、红花、香附、土虫和甲珠共为君药,其中,川芎、香附乃血中之气药,重在调血中之气,气行则血行;甲珠乃祛瘀药之首,与上述当归、丹参、乳香、没药、元胡、桃仁、红花、土虫各药配合应用,共奏活血化瘀,祛瘀止痛,活血通经之功。
黄芪, 性味:甘,微温。归肺、脾、肝、肾经。功效主治:有益气固表,补中益气之功效。
白芍, 性味苦,酸,微寒。归肝,脾经。药物功效:补血,敛阴柔肝,缓急止痛。
巴戟肉, 性微温,味甘、辛。功效主治:肾虚阳痿;风寒湿痹;腰膝酸软;风湿肢气 。洋火叶,为小蘖科植物,淫羊藿,性味,辛苦,温归肝肾经。洋火叶增强温肾壮阳的作用。功效:祛风湿为主,主治风湿寒痹。现代医学研究淫羊藿能抗心肌缺血,延缓衰老,具有增强免疫作用。
故纸,又名木蝴蝶,性味苦,寒。归肺、肝经。《纲目拾遗》:治心气痛,肝气痛,润肺,舒肝。
首乌,性味甘,涩,微温。归肝,肾经。明朝李时珍《本草纲目》记载,首乌能“养血益肝,固精益肾,健筋骨”。
五味子,性味温;酸、甘;归肺、心、肾经。功效主治:益气生津,补肾宁心。
百合,味甘,性微寒。归心、肺经。功能主治:养阴润肺,清心安神。
生地,性味甘,寒。归心、肝、肾经。功能与主治:清热凉血,养阴,生津。 《神农本草经》:味甘,寒。主治折跌,绝筋,伤中,逐血痹,填骨髓,长肌肉。
威灵仙,《本经逢原》载:苦辛,温,小毒。《本草再新》:入肺、肾二经。功效主治,《广西中草药》:祛风除湿,通经活络。
五加皮,性味辛、苦,温。归肝、肾经。功效主治:祛风湿;补肝肾;强筋骨;活血脉。用于风寒湿痹;腰膝疼痛;筋骨痿软;对肝肾不足有风湿者最为适用,可与威灵仙等配伍应用。
方中的黄芪、白芍、巴戟肉、洋火叶、故纸、首乌、五味子、百合、生地、威灵仙和五加皮共为臣药,黄芪重在补气,以补益肝气为主,巴戟肉,洋火叶,故纸,首乌,五味子皆入肾经,五加皮补肾由表入里发挥作用,配合威灵仙祛风湿,取百合,生地滋阴之功,同补肾药相偕为用,中医讲肾主骨生髓,故上药共用补肝肾,强筋骨,去风湿。
榔片,榔片、香附等用来消食、消滞,
内金,气腥,味微苦。
草蔻,性味温,辛,涩。 功能主治:燥温祛寒,除痰截疟,健脾暖胃。
炙山楂,性味酸、甘,微温。归脾、胃、肝经。功用主治:开胃消食、化滞消积、活血散瘀、化痰行气。
神曲,主治食积。
方中的榔片、内金、草蔻、炙山楂、神曲共为佐药,共奏胃之接纳之功,消食健胃,温中祛寒。饮食入胃,游离精气,脾元上输, 输布精微,滋生正气保护中焦不受药气所伤。
葛根,《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。
地龙,性味 咸寒。功用: 清热,镇痉,利尿,解毒。
全虫,《中国药典》载:性味辛,平;有毒。归肝经。功能主治:息风镇痉,攻毒散结,通络止痛。
冰片,《唐本草》载:味辛苦,微寒。《雷公炮制药性解》:入肺、肝二经。功用主治:通诸窍,散郁火,去翳明目,消肿止痛。
枳实,性味苦,辛,寒。归脾,胃,肝,心经。功效主治:积滞内停,痞满胀痛。
方中的川芎、葛根、地龙、全虫、冰片、枳实和元胡共为使药,川芎,葛根乃治疗颈,腰病之重点,引诸药入经,直达病灶。地龙,全虫,冰片具有通窍之功,地龙与葛根互用,达到引经入药之功,枳实破御结之气,调和诸药气。
本发明提供了一种治疗颈椎病的中药组合物,以君臣佐使组方,君药共奏活血化瘀,祛瘀止痛,活血通经之功;臣药共补肝肾,强筋骨,去风湿;佐药共奏胃之接纳之功,消食健胃,温中祛寒,饮食入胃,游离精气,脾元上输, 输布精微,滋生正气保护中焦不受药气所伤;使药调和诸药气,引诸药入经,直达病灶。全方共奏活血化瘀,补益肝肾,扶正祛邪,祛风通络之功,且通过大量临床及药理研究已证明,本发明提供的治疗颈椎病的中药组合物,组方精妙,药性协调,药效可靠持久。
一种治疗颈椎病的中药组合物,按配比,可以用现代中医药技术制成丸剂、片剂、散剂及胶囊剂。
用法及用量:每日3次,每次6克,饭后半小时口服。每14日为一个疗程。用药时间为4-6个疗程。
服用禁忌:对中药过敏者禁用。
疗效判断:根据国家中医药管理局关于颈椎病的诊断依据、证候分类、疗效评定标准规定。
疗效评定:1治愈:原有各型病症消失,肌力正常,颈、肢体功能恢复正常,能参加正常劳动和工作。 2好转:原有各型症状减轻,颈、肩背疼痛减轻,颈、肢体功能改善。 3未愈:症状无改善。
治疗病例及治疗效果统计:按照上述规定,使用本发明的治疗颈椎病的中药组合物治疗颈椎病症患者200例,其中,男100例,女100例;年龄18至70岁;每14日为一个疗程。用药时间为6个疗程。
痊愈为150例,为75%。其中,男 90例,女60例;年龄18 至70 岁,病程最少1年。病程最长6年。
有效为30例,为15%。其中,男18例,女12例,年龄40 至65岁,病程6-8年。
无效为20例;为10%。其中,男8例,女12例;年龄65至70岁,病程8年以上。
有益效果:本发明提供了一种治疗颈椎病的中药组合物,以君臣佐使组方,君药共奏活血化瘀,祛瘀止痛,活血通经之功;臣药共补肝肾,强筋骨,去风湿;佐药共奏胃之接纳之功,消食健胃,温中祛寒,饮食入胃,游离精气,脾元上输, 输布精微,滋生正气保护中焦不受药气所伤;使药调和诸药气,引诸药入经,直达病灶。全方共奏活血化瘀,补益肝肾,扶正祛邪,祛风通络之功,且通过大量临床及药理研究已证明,本发明提供的治疗颈椎病的中药组合物,组方精妙,药性协调,药效可靠持久,不良反应少。痊愈为75%,有效为15%,总有效为90%。本发明提供的一种治疗颈椎病的中药组合物是治疗颈椎病的有效药物,具有重要的临床意义。
具体实施方式
实施例1 一种治疗颈椎病的中药组合物,其特征在于,以君臣佐使组方,其配方及质量g配比为:黄芪30,党参20 ,当归20,丹参20,川芎10,白芍25,桃仁20,红花30,香附20,地龙25,葛根20,生地25,土虫10,威灵仙25,甲珠15,百合25,炙山楂15,神曲15,草蔻9,巴戟肉15,故纸15,洋火叶15,榔片15,内金15,枳实15,首乌25,五味子10,乳香25,没药15,川羌15,元胡20,冰片3,全虫3,五加皮25;
方中的当归、丹参、乳香、没药、元胡、川芎、桃仁、红花、香附、土虫和甲珠共为君药,其中川芎、香附乃血中之气药,重在调血中之气,气行则血行;甲珠乃祛瘀药之首,与上述当归、丹参、乳香、没药、元胡、桃仁、红花、土虫各药配合应用,共奏活血化瘀,祛瘀止痛,活血通经之功;
黄芪、白芍、巴戟肉、洋火叶、故纸、首乌、五味子、百合、生地、威灵仙和五加皮共为臣药,黄芪重在补气,以补益肝气为主,巴戟肉,洋火叶,故纸,首乌,五味子皆入肾经,五加皮补肾由表入里发挥作用,配合威灵仙祛风湿,取百合,生地滋阴之功,同补肾药相偕为用,中医讲肾主骨生髓,故上药共用补肝肾,强筋骨,去风湿。共为臣药。
方中的榔片、内金、草蔻、炙山楂、神曲共为佐药,共奏胃之接纳之功,消食健胃,温中祛寒。饮食入胃,游离精气,脾元上输, 输布精微,滋生正气保护中焦不受药气所伤。
方中的川芎、葛根、地龙、全虫、冰片、枳实和元胡共为使药,川芎,葛根乃治疗颈,腰病之重点,引诸药入经,直达病灶。地龙,全虫,冰片具有通窍之功,地龙与葛根互用,达到引经入药之功,枳实破御结之气,调和诸药气。
一种治疗颈椎病的中药组合物,以君臣佐使组方,君药共奏活血化瘀,祛瘀止痛,活血通经之功;臣药共补肝肾,强筋骨,去风湿;佐药共奏胃之接纳之功,消食健胃,温中祛寒,饮食入胃,游离精气,脾元上输, 输布精微,滋生正气保护中焦不受药气所伤;使药调和诸药气,引诸药入经,直达病灶。全方共奏活血化瘀,补益肝肾,扶正祛邪,祛风通络之功,且通过大量临床及药理研究已证明,本发明提供的治疗颈椎病的中药组合物,组方精妙,药性协调,药效可靠持久。
一种治疗颈椎病的中药组合物,按配比,可以用现代中医药技术制成丸剂、片剂、散剂及胶囊剂。
用法及用量:每日3次,每次6克,饭后半小时口服。每14日为一个疗程。用药时间为4-6个疗程。
服用禁忌:对中药过敏者禁用。
疗效判断:根据国家中医药管理局关于颈椎病的诊断依据、证候分类、疗效评定标准规定。
疗效评定:1治愈:原有各型病症消失,肌力正常,颈、肢体功能恢复正常,能参加正常劳动和工作。 2好转:原有各型症状减轻,颈、肩背疼痛减轻,颈、肢体功能改善。 3未愈:症状无改善。
治疗病例及治疗效果统计:按照上述规定,使用本发明的治疗颈椎病的中药组合物治疗颈椎病症患者200例,其中,男100例,女100例;年龄18至70岁;每14日为一个疗程。用药时间为6个疗程。
痊愈为150例,为75%。其中,男 90例,女60例;年龄18 至70 岁,病程最少1年。病程最长6年。
有效为30例,为15%。其中,男18例,女12例,年龄40至65岁,病程6-8年。
无效为20例;为10%。其中,男8例,女12例;年龄65至70岁,病程8年以上。
Claims (1)
1.一种治疗颈椎病的中药组合物,其特征在于,以君臣佐使组方,所用原料药及其重量比为:黄芪30,党参20 ,当归20,丹参20,川芎10,白芍25,桃仁20,红花30,香附20,地龙25,葛根20,生地25,土虫10,威灵仙25,甲珠15,百合25,炙山楂15,神曲15,草蔻9,巴戟肉15,故纸15,洋火叶15,榔片15,内金15,枳实15,首乌25,五味子10,乳香25,没药15,川羌15,元胡20,冰片3,全虫3,五加皮25;其中,当归、丹参、乳香、没药、元胡、川芎、桃仁、红花、香附、土虫和甲珠共为君药;黄芪、白芍、巴戟肉、洋火叶、故纸、首乌、五味子、百合、生地、威灵仙和五加皮共为臣药;榔片、内金、草蔻、炙山楂和神曲共为佐药;川芎、葛根、地龙、全虫、冰片、枳实和元胡共为使药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100575851A CN102600414B (zh) | 2012-03-07 | 2012-03-07 | 一种治疗颈椎病的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100575851A CN102600414B (zh) | 2012-03-07 | 2012-03-07 | 一种治疗颈椎病的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600414A CN102600414A (zh) | 2012-07-25 |
| CN102600414B true CN102600414B (zh) | 2013-09-04 |
Family
ID=46518433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100575851A Expired - Fee Related CN102600414B (zh) | 2012-03-07 | 2012-03-07 | 一种治疗颈椎病的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600414B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920879A (zh) * | 2012-11-21 | 2013-02-13 | 王云 | 一种治疗颈椎病的中药组合物 |
| CN109453285A (zh) * | 2018-12-29 | 2019-03-12 | 大连民族大学 | 一种治疗颈椎增生的中药 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926969A (zh) * | 2010-06-03 | 2010-12-29 | 陕西中医学院 | 一种治疗神经根型颈椎病的中药组合物及其制备方法 |
| CN102119989A (zh) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 |
| CN102125664A (zh) * | 2010-10-27 | 2011-07-20 | 宋爱民 | 治疗颈椎病的中药制剂 |
-
2012
- 2012-03-07 CN CN2012100575851A patent/CN102600414B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926969A (zh) * | 2010-06-03 | 2010-12-29 | 陕西中医学院 | 一种治疗神经根型颈椎病的中药组合物及其制备方法 |
| CN102125664A (zh) * | 2010-10-27 | 2011-07-20 | 宋爱民 | 治疗颈椎病的中药制剂 |
| CN102119989A (zh) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 |
Non-Patent Citations (2)
| Title |
|---|
| 中医药防治颈椎病研究现状;谢运飞等;《光明中医》;20120131;第27卷(第1期);第193-195页 * |
| 谢运飞等.中医药防治颈椎病研究现状.《光明中医》.2012,第27卷(第1期),第193-195页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600414A (zh) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872299B (zh) | 一种治疗骨质疏松、骨质疏松骨折的药物组合物 | |
| CN101972453B (zh) | 一种治疗风湿类风湿关节炎的中药药酒及其制备方法 | |
| CN103463404B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
| CN103393879B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
| CN103212040A (zh) | 一种治疗脂溢性脱发的中药组合物 | |
| CN103536758A (zh) | 一种治疗阴虚盗汗的中药组合物 | |
| CN103110762A (zh) | 一种治疗骨折久不愈合的中药组合物 | |
| CN104306540B (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
| CN102698093B (zh) | 一种治疗肝肾阴虚型高血压的中药组合物及其制备方法 | |
| CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
| CN102600414B (zh) | 一种治疗颈椎病的中药组合物 | |
| CN104208265A (zh) | 治疗类风湿关节炎的中药组合物 | |
| CN102406904A (zh) | 一种治疗眩晕症的中药组合物 | |
| CN104721644A (zh) | 一种用于膝关节骨性关节炎的中药制剂及其制备方法 | |
| CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
| CN105213766B (zh) | 一种通络养膝汤及其制备方法 | |
| CN102512543B (zh) | 一种治疗类风湿的中药组合物 | |
| CN102579672A (zh) | 一种治疗骨质增生和腰椎间盘突出的药物 | |
| CN101703645B (zh) | 治疗颈椎骨质增生的中药组合物 | |
| CN101703660B (zh) | 一种抗衰老药物 | |
| CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
| CN105796815A (zh) | 一种补肾壮骨酒及其制备方法 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN103784720A (zh) | 一种降血糖尿糖的中药制剂 | |
| CN101181608A (zh) | 戒毒药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130904 Termination date: 20140307 |